Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Human ILC1s Target Leukemia Stem Cells and Control Development of AML

Zhenlong Li, Hejun Tang, Victoria Chen, Rui Ma, Jianying Zhang, Guido Marcucci, Jianhua Yu, Michael A Caligiuri

Blood (2023) 142 (Supplement 1): 886.

https://doi.org/10.1182/blood-2023-190767

Published: 2023

Journal Articles

The NK Cell Receptor NKp46 Acts As an Essential Regulator of ILC1 Proliferation, Effector Function and Anti-AML Activity

Rui Ma, Zhenlong Li, Hejun Tang, Lei Tian, Zahir Shah, Tasha Barr, Amy Peng, Jianying Zhang, Srividya Swaminathan, Michael A Caligiuri, Jianhua Yu

Blood (2023) 142 (Supplement 1): 3925.

https://doi.org/10.1182/blood-2023-191070

Published: 2023

Journal Articles

Acquired microRNA-142 Deficit Drives Escape Mechanisms of Anti-Leukemic Surveillance during Blast Crisis Transformation of Chronic Myeloid Leukemia (CML)

Blood (2023) 142 (Supplement 1): 3152.

https://doi.org/10.1182/blood-2023-182587

Published: 2023

Journal Articles

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

Caroline Duault, Anil Kumar, Adeleh Taghi Khani, Sung June Lee, Lu Yang, Min Huang, Christian Hurtz, Bryan Manning, Lucy Ghoda, Tinisha McDonald, Norman J. Lacayo, Kathleen M. Sakamoto, Martin Carroll, Sarah K. Tasian, Guido Marcucci, Jianhua Yu, Michael A. Caligiuri, Holden T. Maecker, Srividya Swaminathan

Blood (2021) 138 (16): 1465–1480.

https://doi.org/10.1182/blood.2020009871

Published: 2021

Includes: Supplemental data

Journal Articles

Activated Natural Killer Cells Are Associated with Poor Clinical Prognosis in High-Risk B- and T- Cell Acute Lymphoblastic Leukemia

Caroline Duault, PharmD, PhD, Anil Kumar, PhD, Adeleh Taghi Khani, PhD, Sung June Lee, BA, Lu Yang, PhD, Min Huang, PhD, Christian Hurtz, PhD, Bryan Manning, BS, Lucy Ghoda, PhD, Tinisha McDonald, BS, Norman J. Lacayo, MD, Kathleen M. Sakamoto, MD PhD, Martin P. Carroll, MD, Guido Marcucci, MD, Jianhua Yu, PhD, Michael A. Caligiuri, MD, Holden T. Maecker, PhD, Srividya Swaminathan, PhD

Blood (2020) 136 (Supplement 1): 39.

https://doi.org/10.1182/blood-2020-140044

Published: 2020

Journal Articles

The ETS1 Transcription Factor Is Implicated in Human and Murine Intermediate NK Cell Development Stages

Eileen Hu, BS, Jessica Waibl-Polania, BS, Frank Frissora, MS, Larry State Beaver, Kevan Zapolnik, BS, Bethany L Mundy-Bosse, PhD, Anjali Mishra, PhD, Aharon G. Freud, MD PhD, Jianhua Yu, PhD, John C. Byrd, MD, Christopher C. Oakes, Michael Ostrowski, PhD, Natarajan Muthusamy, DVM, PhD

Blood (2018) 132 (Supplement 1): 2567.

https://doi.org/10.1182/blood-2018-99-115261

Published: 2018

Journal Articles

Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function

Blood (2018) 132 (17): 1792–1804.

https://doi.org/10.1182/blood-2018-03-838474

Published: 2018

Includes: Supplemental data

Journal Articles

Combination Therapy with Daratumumab and CAR-NK Targeting CS1 for Multiple Myeloma

Yibo Zhang, PhD, Lichao Chen, Yufeng Wang, Xinxin Li, Tiffany Hughes, Hans Klingemann, Don M Benson, MD PhD, Jianhua Yu, PhD

Blood (2016) 128 (22): 1342.

https://doi.org/10.1182/blood.V128.22.1342.1342

Published: 2016

Journal Articles

Decitabine enhances anti-CD33 monoclonal antibody BI 836858–mediated natural killer ADCC against AML blasts

Blood (2016) 127 (23): 2879–2889.

https://doi.org/10.1182/blood-2015-11-680546

Published: 2016

Includes: Supplemental data

Journal Articles

Enhancement of Natural Killer Cell Interferon-Gamma Production By the Derivatives of the Natural Product Phyllanthusmins Via TLR-Mediated NF-Kb and STAT3 Signaling Pathways

Luxi Chen, Long Yi, Yuning Ren, Jianying Zhang, A. Douglas Kinghorn, Michael A. Caligiuri, MD, Jianhua Yu, PhD

Blood (2015) 126 (23): 1031.

https://doi.org/10.1182/blood.V126.23.1031.1031

Published: 2015

Journal Articles

Modulation of Natural Killer Cell Activity in the Setting of Oncolytic Virotherapy and with a Chimeric Antigen Receptor

Chen Xilin, Jianfeng Han, Chu Jianhong, Walter Meisen, Zhang Jianying, E. Antonio Chiocca, Balveen Kaur, Michael A. Caligiuri, MD, Jianhua Yu, PhD

Blood (2015) 126 (23): 210.

https://doi.org/10.1182/blood.V126.23.210.210

Published: 2015

Journal Articles

Remission of a Heavily Pre-Treated Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma after Treatment with Metronomic Therapy

Yuan Shunzong, MD, Haverkos Brad, Hang Su, Jianhua Yu, PhD

Blood (2014) 124 (21): 5456.

https://doi.org/10.1182/blood.V124.21.5456.5456

Published: 2014

Journal Articles

Acute Myeloid Leukemia Alters Natural Killer Cell Maturation and Functional Activation

Bethany Mundy-Bosse, PhD, McConnell Kathleen, Charlene Mao, Elshafa Ahmed, Li Chen, Steven D Scoville, Aharon G. Freud, MD PhD, Jianhua Yu, PhD, Michael A. Caligiuri, MD

Blood (2014) 124 (21): 754.

https://doi.org/10.1182/blood.V124.21.754.754

Published: 2014

Journal Articles

Nanoparticle-Encapsulated Allogeneic T Cells Mitigate Graft-Versus-Host Disease but Retain Graft-Versus-Leukemia Activity

Lingling Zhang, PhDMD, Shuting Zhao, Steven M. Devine, MD, Xiaoming He, PhD, Jianhua Yu, PhD

Blood (2014) 124 (21): 3820.

https://doi.org/10.1182/blood.V124.21.3820.3820

Published: 2014

Journal Articles

CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells and T Cells Enhance In Vitro and In Vivo Anti-Tumor Activity Against Human Multiple Myeloma

Jianhong Chu, PhD, Youcai Deng, Don M. Benson, Jr., MD, PhD, Shun He, Tiffany L. Hughes, Jianying Zhang, Yong Peng, Hsiaoyin Mao, Ling Yi, Kalpana Ghoshal, Xiaoming He, Steven M. Devine, MD, Xiaoliu Zhang, Michael A. Caligiuri, MD, Craig C. Hofmeister, MD, Jianhua Yu, PhD

Blood (2013) 122 (21): 14.

https://doi.org/10.1182/blood.V122.21.14.14

Published: 2013

Journal Articles

Decitabine Or 5-Azacitidine Pre-Treatment Does Not Compromise The Novel Fc-Engineered Antibody Mab 33.1-Mediated ADCC Against Primary AML Blasts - A Rationale For Combination Therapy

Shun He, PhD, Carolyn Cheney, Susan P. Whitman, PhD, Jianhua Yu, PhD, Sumithira Vasu, MBBS, William Blum, MD, Karl-Heinz Heider, PhD, Guido Marcucci, MD, Natarajan Muthusamy, DVM, Ph.D

Blood (2013) 122 (21): 3959.

https://doi.org/10.1182/blood.V122.21.3959.3959

Published: 2013

Journal Articles

FLT3L and AMD3100 Combination Increases Hematopoietic Stem Cell Mobilization and Leads To Improved Transplantation Outcome

Shun He, PhD, Deng Youcai, MS, Sumithira Vasu, MBBS, Jianhong Chu, Shunzong Yuan, Jianying Zhang, Zhijin Fan, Craig C Hofmeister, MD, Xiaoming He, Henry March, Steven M. Devine, MD, Jianhua Yu, PhD

Blood (2013) 122 (21): 901.

https://doi.org/10.1182/blood.V122.21.901.901

Published: 2013

Journal Articles

MicroRNAs activate natural killer cells through Toll-like receptor signaling

Shun He, Jianhong Chu, Lai-Chu Wu, Hsiaoyin Mao, Yong Peng, Christopher A. Alvarez-Breckenridge, Tiffany Hughes, Min Wei, Jianying Zhang, Shunzong Yuan, Sumeet Sandhu, Sumithira Vasu, Don M. Benson, Jr, Craig C. Hofmeister, Xiaoming He, Kalpana Ghoshal, Steven M. Devine, Michael A. Caligiuri, Jianhua Yu

Blood (2013) 121 (23): 4663–4671.

https://doi.org/10.1182/blood-2012-07-441360

Published: 2013

Includes: Supplemental data

Journal Articles

Micrornas Promote Activation and Maturation of Natural Killer Cells Through Toll-Like Receptor Signaling.

Jianhua Yu, PhD, Shun He, Lai-Chu Wu, PhD, Hsiaoyin Mao, Sumithira Vasu, MBBS, Samantha M. Jaglowski, MD, MPH, Yong Peng, Christopher Alvarez-Breckenridge, Shunzong Yuan, Ph.D., M.D., Min Wei, Jianying Zhang, Tiffany L Hughes, Kalpana Ghoshal, Steven M. Devine, MD, Michael A. Caligiuri, M.D.

Blood (2012) 120 (21): 2160.

https://doi.org/10.1182/blood.V120.21.2160.2160

Published: 2012

Journal Articles

Immune Reconstitution At Days 30 and 100 Following Allogeneic Stem Cell Transplant and Association with Subsequent Development of Chronic Graft-Versus-Host Disease

Samantha M. Jaglowski, MD, MPH, Sumithira Vasu, MBBS, Susan Geyer, PhD, Anissa Bingman, M.S., Patrick Elder, MS, Jianhua Yu, PhD, William Blum, MD, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, M.D., Craig C. Hofmeister, MD, Don M. Benson, Jr., MD, PhD, Natarajan Muthusamy, DVM, Ph.D, Steven M. Devine, MD, Leslie A Andritsos, MD, Gerard Lozanski, MD

Blood (2012) 120 (21): 1949.

https://doi.org/10.1182/blood.V120.21.1949.1949

Published: 2012

NARROW

Human ILC1s Target Leukemia Stem Cells and Control Development of AML

The NK Cell Receptor NKp46 Acts As an Essential Regulator of ILC1 Proliferation, Effector Function and Anti-AML Activity

Acquired microRNA-142 Deficit Drives Escape Mechanisms of Anti-Leukemic Surveillance during Blast Crisis Transformation of Chronic Myeloid Leukemia (CML)

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

Activated Natural Killer Cells Are Associated with Poor Clinical Prognosis in High-Risk B- and T- Cell Acute Lymphoblastic Leukemia

The ETS1 Transcription Factor Is Implicated in Human and Murine Intermediate NK Cell Development Stages

Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function

Combination Therapy with Daratumumab and CAR-NK Targeting CS1 for Multiple Myeloma

Decitabine enhances anti-CD33 monoclonal antibody BI 836858–mediated natural killer ADCC against AML blasts

Enhancement of Natural Killer Cell Interferon-Gamma Production By the Derivatives of the Natural Product Phyllanthusmins Via TLR-Mediated NF-Kb and STAT3 Signaling Pathways

Modulation of Natural Killer Cell Activity in the Setting of Oncolytic Virotherapy and with a Chimeric Antigen Receptor

Remission of a Heavily Pre-Treated Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma after Treatment with Metronomic Therapy

Acute Myeloid Leukemia Alters Natural Killer Cell Maturation and Functional Activation

Nanoparticle-Encapsulated Allogeneic T Cells Mitigate Graft-Versus-Host Disease but Retain Graft-Versus-Leukemia Activity

CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells and T Cells Enhance In Vitro and In Vivo Anti-Tumor Activity Against Human Multiple Myeloma

Decitabine Or 5-Azacitidine Pre-Treatment Does Not Compromise The Novel Fc-Engineered Antibody Mab 33.1-Mediated ADCC Against Primary AML Blasts - A Rationale For Combination Therapy

FLT3L and AMD3100 Combination Increases Hematopoietic Stem Cell Mobilization and Leads To Improved Transplantation Outcome

MicroRNAs activate natural killer cells through Toll-like receptor signaling

Micrornas Promote Activation and Maturation of Natural Killer Cells Through Toll-Like Receptor Signaling.

Immune Reconstitution At Days 30 and 100 Following Allogeneic Stem Cell Transplant and Association with Subsequent Development of Chronic Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only